Silgan Q2 Beat, Confirms 2026 Outlook; Pet Food and Fragrance Volumes Drive Growth
SLGN sits 20% above its 52-week low of $35.68 on elevated volume (3.4× avg).
Summary
Silgan Holdings reported Q2 2026 adjusted EPS of $0.98 on revenue of $1.64B, beating estimates, and confirmed its full-year outlook. Volume growth in pet food and fragrance markets and a new supply agreement highlight operational momentum.
Key Events · Earnings and Guidance · SLGN
-
Q2 Earnings Beat
Adjusted EPS of $0.98 on revenue of $1.64B, exceeding consensus by $0.02 and $20M respectively. GAAP EPS was $0.72, impacted by $0.26 in adjustments including rationalization charges and amortization.
-
Full-Year Guidance Confirmed
Adjusted EPS guidance of $3.73–$3.93 reaffirmed, representing 3% growth at the midpoint over 2025's $3.72. Free cash flow expected at ~$450M.
-
Volume Growth in Key Markets
High single-digit volume growth in metal containers for pet food and dispensing products for fragrance markets, partially offset by lower soup and Brazil dispensing volumes.
-
New Supply Agreement Secured
Executed a long-term supply agreement with a large vegetable pack customer, adding revenue visibility in the Metal Containers segment.
Analysis · SLGN · Manufacturing
A clean Q2 beat underscores Silgan's operational momentum, with revenue of $1.64B and adjusted EPS of $0.98 topping consensus by $20M and $0.02, respectively. The company confirmed its full-year adjusted EPS guidance of $3.73–$3.93 and set Q3 guidance at $1.21–$1.31, both in line with expectations. Volume strength in pet food metal containers and fragrance dispensing closures offset softer soup and Brazil dispensing volumes. A new long-term vegetable pack supply agreement adds visibility. The results reinforce the company's ability to pass through raw material costs and execute on cost reduction plans, though higher corporate expenses and rationalization charges weighed on GAAP earnings.
At the time of this filing, SLGN was trading at $42.65 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $35.68 to $55.92. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.